Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-01 Sale | 2024-08-05 4:49 pm | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 65,693,524 | $0 | $0 | 0 (Indirect Direct) | View |
| 2023-10-16 Purchase | 2023-10-18 4:30 pm | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 5,480,052 | $22.81 | $124,999,986 | 65,683,063 (Indirect Direct) | View |
| 2021-08-10 Sale | 2021-08-12 8:38 pm | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 1,000,000 | $70.25 | $70,250,000 | 4,832,413 (Indirect Direct) | View |
| 2021-07-19 Purchase | 2021-07-21 4:40 pm | RAPID MICRO BIOSYSTEMS INC. | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 100,000 | $20 | $2,000,000 | 8,434,560 (Indirect) | View |
| 2021-03-09 Sale | 2021-03-11 4:30 pm | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 1,450,000 | $71.5 | $103,675,000 | 5,831,307 (Indirect) | View |
| 2020-12-10 Sale | 2020-12-14 5:35 pm | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 1,000,000 | $23.4 | $23,400,000 | 3,080,237 (Indirect) | View |
| 2020-11-09 Purchase | 2020-11-12 5:54 pm | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 332,293 | $10.3 | $3,422,618 | 60,632,356 (Indirect) | View |
| 2020-10-27 Purchase | 2020-10-29 8:00 pm | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 10,000,000 | $10 | $100,000,000 | 110,262,006 (Indirect) | View |
| 2020-10-26 Purchase | 2020-10-27 5:07 pm | Aptinyx Inc. | APTX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 3,333,333 | $3 | $9,999,999 | 8,891,758 (Indirect) | View |
| 2020-07-28 Purchase | 2020-07-28 4:45 pm | Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Bain Capital Life Sciences Partners LP Schwartz Jeffrey Lawrence 10% Owner | 400,000 | $17 | $6,800,000 | 3,241,628 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-26 Option Award | 2024-06-28 4:00 pm | 2025-06-26 2034-06-25 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 16,000 | $5.52 | 16,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:12 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 10,461 | $0 | 65,693,524 (Direct) | View |
| 2024-01-11 Option Award | 2024-01-12 4:56 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 904,160 | $5.53 | 4,034,582 (Indirect) | View |
| 2023-06-21 Option Award | 2023-06-22 8:12 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-07 Other | 2023-06-09 5:07 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 432,627 | $0 | 60,649,418 (Indirect) | View |
| 2023-06-07 Option Award | 2023-06-09 5:07 pm | N/A 2033-06-07 | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 17,062 | $0 | 60,649,418 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 5:01 pm | N/A 2033-06-06 | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 9,650 | $0 | 9,650 (Direct) | View |
| 2022-12-13 Option Award | 2022-12-15 6:19 pm | N/A 2032-12-13 | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 9,650 | $0 | 9,650 (Direct) | View |
| 2022-12-02 Option Award | 2022-12-05 5:16 pm | N/A 2032-12-01 | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 2,666 | $0 | 2,666 (Direct) | View |
Ownership | 2022-12-05 4:58 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 0 | $0 | 3,130,423 (Indirect) | View |
| 2022-06-21 Option Award | 2022-06-22 8:59 pm | 2023-06-21 2032-06-20 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:10 pm | N/A 2032-06-14 | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 23,459 | $0 | 23,459 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 5:06 pm | N/A 2032-05-25 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-12-28 Equity Swap | 2021-12-29 4:43 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 3,083,570 | $38.25 | 0 (Direct) | View |
| 2021-07-19 Conversion | 2021-07-21 4:40 pm | N/A N/A | RAPID MICRO BIOSYSTEMS INC. | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 50,007,380 | $0 | 8,434,560 (Indirect) | View |
Ownership | 2021-07-14 8:02 pm | N/A N/A | RAPID MICRO BIOSYSTEMS INC. | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 0 | $0 | 8,334,560 (Indirect) | View |
| 2021-07-13 Option Award | 2021-07-14 4:53 pm | 2022-07-13 2031-07-12 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 12,530 | $0 | 12,530 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 5:15 pm | N/A 2031-06-16 | Solid Biosciences Inc. | SLDB | Koppel Adam Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:25 pm | N/A 2031-06-10 | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 42,950 | $0 | 42,950 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 6:50 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 18,333 | $0 | 3,101,903 (Direct) | View |
| 2021-06-03 Exercise | 2021-06-07 6:50 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 3,333 | $0 | 3,101,903 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 4:30 pm | N/A 2031-05-26 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-23 Option Award | 2021-03-25 4:30 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Koppel Adam Director | 869,565 | $5.75 | 7,929,918 (Indirect) | View |
| 2020-12-31 Option Award | 2021-01-05 4:44 pm | N/A 2030-12-30 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 5,508 | $2.224 | 5,508 (Direct) | View |
| 2020-12-10 Option Award | 2020-12-11 4:30 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Koppel Adam Director | 3,189,189 | $3.7 | 7,060,353 (Indirect) | View |
| 2020-10-27 Other | 2020-10-29 8:00 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 49,961,943 | $0 | 110,262,006 (Indirect) | View |
Ownership | 2020-10-29 7:45 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director | 0 | $0 | 338,120 (Indirect) | View |
| 2020-10-26 Option Award | 2020-10-26 4:30 pm | N/A N/A | BCLS Acquisition Corp. | BLSA | Koppel Adam Director 10% Owner | 487,500 | $10 | 487,500 (Indirect) | View |
Ownership | 2020-10-22 9:03 pm | N/A 2028-01-30 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 0 | $0 | 94,594 (Direct) | View |
Ownership | 2020-10-21 8:05 pm | N/A N/A | BCLS Acquisition Corp. | BLSA | Koppel Adam Director 10% Owner | 0 | $0 | 3,503,750 (Indirect) | View |
| 2020-09-30 Option Award | 2020-10-02 4:15 pm | N/A 2030-09-29 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 5,663 | $2.163 | 5,663 (Direct) | View |
| 2020-07-28 Conversion | 2020-07-28 4:45 pm | N/A N/A | Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Bain Capital Life Sciences Partners LP Schwartz Jeffrey Lawrence 10% Owner | 27,876,392 | $0 | 3,241,628 (Indirect) | View |
Ownership | 2020-07-23 5:06 pm | N/A N/A | Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 0 | $0 | 25,034,764 (Indirect) | View |